Associate Director, US Pricing, Contracting and Channel Strategy

Build our future together

Regeneron is seeking an Associate Director of US Pricing, Contracting, and Channel Strategy to shape how our medicines reach patients across the U.S. In this role, you’ll lead channel strategy for both new launches and in-line brands across a portfolio that spans ophthalmology, immunology, oncology, cardiovascular, and rare disease. You’ll also own pricing and contracting strategy for our rare disease and gene therapy portfolio, where small patient populations and high-value therapies call for thoughtful, sustainable access solutions.

You’ll work at the intersection of brand, market access, trade, finance, legal, and patient services, making sure every pricing, contracting, and channel decision supports access, affordability, and a seamless experience for patients, providers, and payers. This is a high-visibility role for a strategic problem solver who understands the mechanics of pharmaceutical distribution and pricing and can turn complex market dynamics into clear, actionable recommendations for senior leadership.

When & where

Remote: Travel 10-15% for internal meetings and customer engagements

Channel Strategy (Portfolio-Wide)

Develop and lead channel strategies for pipeline assets and launch products, including distribution model selection (specialty pharmacy, specialty distribution, limited or exclusive networks, buy-and-bill, home infusion, direct-to-consumer, and retail), well ahead of approval.

Evaluate and optimize channel performance for in-line brands, finding opportunities to improve patient access, speed to therapy, pull-through, data visibility, and gross-to-net efficiency.

Partner with Trade Account Directors to shape distribution and service agreements with wholesalers, specialty distributors, and specialty pharmacies, including fee-for-service structures and data requirements.

Partner with Supply Chain on stocking and distribution plans for product launches, and on channel response to discontinuations, supply constraints, and back orders.

Identify and develop new strategic channel partners and programs, including emerging digital and alternative dispensing models, that support evolving patient and provider needs.

Establish benchmarks and performance metrics to measure the effectiveness of channel strategies, partnerships, and access initiatives, using channel data (867, 852, specialty pharmacy dispense data, and third-party sources).

Pricing and Contracting Strategy (Rare Disease and Gene Therapy)

Lead U.S. launch and in-line pricing strategy for rare disease and gene therapy assets, including price-setting analyses, payer research, scenario modeling, and price governance.

Develop contracting strategies with commercial payers, PBMs, and providers to secure and sustain patient access.

Evaluate innovative contracting and payment approaches, such as outcomes-based agreements, where they can strengthen access and value.

Partner with HEOR and Market Access Strategy teams to build the evidence and value narrative that supports pricing and contracting decisions.

Model contract performance and gross-to-net impact, and monitor results against expectations after execution.

Market Intelligence

Maintain a deep understanding of how payers and channel customers make purchasing, stocking, and coverage decisions.

Maintain a deep understanding of buy-and-bill dynamics for medical benefit physician administered products to ensure access at large organized customers.

Monitor competitor pricing, contracting, and channel strategies, and anticipate competitive moves to keep Regeneron’s approach differentiated and forward-looking.